3
Announcements
Trials
Browse
Landscape
Status
Completed
1
Sponsor Class
OTHER_GOV
1
Study Type
Observational
1
Sponsor
Cancer Type
Thoracic
1
Conditions
Small Cell Lung Carcinoma
4
Lung Neoplasms
4
Carcinoma, Non-Small-Cell Lung
4
Unresectable Hepatocellular Carcinoma
1
Squamous Cell Carcinoma of Head and Neck
1
Sarcopenia
1
Recurrent Squamous Cell Lung Carcinoma
1
Parkinson Disease 4, Autosomal Dominant Lewy Body
1
Oropharyngeal Neoplasms
1
Non-Small Cell Lung Cancer NSCLC
1
Neoplasms
1
Melanoma
1
Kidney Neoplasms
1
Hepatobiliary Cancers
1
Head and Neck Neoplasms
1
Deglutition Disorders
1
Interventions
Ultrasonography
3
Walking Speed
2
Tomography, X-Ray Computed
2
Hand Strength
2
Gastrectomy
2
Esophagectomy
2
pembrolizumab
1
durvalumab
1
atezolizumab
1
Testosterone
1
Standard of Care
1
Preoperative Exercise
1
Nivolumab
1
Immunotherapy
1
Immune Checkpoint Inhibitors
1
Hepatectomy
1
Goserelin
1
Gonadotropin-Releasing Hormone
1
Exercise Test
1
Colectomy
1
Chemotherapy, Adjuvant
1
Carboplatin
1
CP protocol
1
Adiposity
1
4-azidosalicylic acid-phosphatidylserine
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Observational
×
Sarcopenia
×
durvalumab
×
Clear all
NCT07192926
2026-02-20
SARCO-CTI
Ankara Etlik City Hospital
Completed
131 enrolled